BETH ISRAEL DEACONESS MEDICAL CENTER
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1896-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.bidmc.org/
Impaired Wound Healing in Diabetic Foot Ulceration
- Conditions
- Diabetes MellitusHealthy Volunteers
- First Posted Date
- 2008-08-21
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 137
- Registration Number
- NCT00739323
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Device: NIR imaging system
- First Posted Date
- 2008-07-24
- Last Posted Date
- 2013-02-18
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT00721370
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache
- Conditions
- Episodic Migraine
- Interventions
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 76
- Registration Number
- NCT00719134
- Locations
- πΊπΈ
Pain Clinic at Beth Israel Deaconess Medical Center, Brookline, Massachusetts, United States
Matrix Biology of Tracheobronchomalacia and Tracheal Stenosis
- Conditions
- TracheobronchomalaciaTracheal Stenosis
- First Posted Date
- 2008-06-26
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT00705848
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
- Conditions
- Acute Lymphocytic LeukemiaRelapsed/Refractory Chronic Lymphocytic LeukemiaAcute Myeloid LeukemiaHodgkins DiseaseMyelodysplastic SyndromeRelapsed/Refractory Non Hodgkin's LymphomaRelapsed Refractory Multiple Myeloma
- Interventions
- Drug: Antithymocyte Globulin
- First Posted Date
- 2008-06-16
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT00697684
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Statin Therapy in the Treatment of Sepsis
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT00676897
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Gas Embolism With Use of Argon Plasma Coagulation
- Conditions
- Embolism, Air
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT00676858
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00676585
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Linkage Analysis in Interstitial Cystitis
- Conditions
- Urinary Bladder, OveractivePainful Bladder SyndromeCystitis, InterstitialProstatitisChronic Pelvic Pain Syndrome
- First Posted Date
- 2008-05-09
- Last Posted Date
- 2017-02-03
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT00675298
- Locations
- πΊπΈ
Jordan D Dimitrakoff, Boston, Massachusetts, United States
Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 57
- Registration Number
- NCT00673127
- Locations
- πΊπΈ
Sidney Kimmel Comprehensive Cancer Center at John Hopkins University, Baltimore, Maryland, United States
πΊπΈDana-Farber Cancer Institute, Boston, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States